June 18, 2019

June 17, 2019

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

Date Title Organization
13
May
Beer, Hemp, and CBD in North Carolina Ward and Smith, P.A.
13
May
FDA’s Quiet Reorganization of the Office of Food Additive Safety Begins Today Keller and Heckman LLP
13
May
Update: New York City’s Ban On Pre-Employment Marijuana Testing Will Take Effect on May 10, 2020 Jackson Lewis P.C.
11
May
EC JRC Announces Publication of Article on Measuring Nanoparticles in Medicinal Products Bergeson & Campbell, P.C.
10
May
Strength in Numbers: Why Forming a TSCA Consortium Is Important Bergeson & Campbell, P.C.
10
May
2018 Farm Bill and Federal Trademark Protection for Hemp Ward and Smith, P.A.
10
May
McDermottPlus Check-Up: May 10, 2019 McDermott Will & Emery
10
May
FDA Issues Guidance on FCNs for Substances Intended to Contact Infant Formula Keller and Heckman LLP
10
May
Product Recalls Decline Across All Industries in Q1 2019 Keller and Heckman LLP
9
May
Co-Pay Kickbacks at Center of $122M in Settlement Fees for Alleged Medicare Fraud Tycko & Zavareei LLP
9
May
CMS Finalizes Rule Requiring Disclosure of Drug Prices in TV Ads Mintz
9
May
Compliance Inspections for CBD Retail Operations in NC Ward and Smith, P.A.
9
May
Florida Now Requires Physicians to Inform Patients About Non-Opioid Alternatives Polsinelli PC
9
May
California’s Proposition 65 Website Posts Styrene Fact Sheet Keller and Heckman LLP
9
May
FDA Adds “Black Box” Warning Label to Sleep Drugs Including Ambien, Lunesta Stark & Stark
8
May
CBD Risk Management Wilson Elser Moskowitz Edelman & Dicker LLP
8
May
AAFCO Issues Updated Guidelines Regarding Hemp in Animal Food Sheppard, Mullin, Richter & Hampton LLP
8
May
FMCSA Clearinghouse Rules Take Effect On January 6, 2020: Are You Ready? Jackson Lewis P.C.
8
May
Sharpless: ‘No Pause’ Following Gottlieb’s Departure Keller and Heckman LLP
7
May
Prop 65 Fact Sheet for Styrene Includes Perplexing Recommendation Keller and Heckman LLP

Pages

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS